肿瘤晚期患者生存期预测研究进展
|
摘要
从肿瘤晚期患者的预后因素、肿瘤晚期患者生存期的评估工具、国内外相关的研究现状等进行综述,为建立符合我国特点的晚期肿瘤患者生存期预测的评估工具,探索患者进入安宁疗护的最佳时机提供依据。
引文
[1]Chen W,Sun K,Zheng R,et al.Cancer incidence and mortality in China,2014[J].Chin J Cancer Res,2018,30(1):1-12.
[2]Kishi T,Matsuo Y,Ueki N,et al.Pretreatment Modified Glasgow Prognostic Score predicts clinical outcomes after stereotactic body radiation therapy for early-stage non-small cell lung cancer[J].Int J Radiat Oncol,2015,92(3):619-626.
[3]Hyman DM,Eaton AA,Gounder MM,et al.Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials[J].J Clin Oncol,2014,32(6):519-526.
[4]Jeba J,Cherian RM,Thangakunam B,et al.Prognostic factors of malignant pleural effusion among palliative care outpatients:a retrospective study[J].Indian J Palliat Care,2018,24(2):184-188.
[5]Hui D.Prognostication of survival in patients with advanced cancer:predicting the unpredictable[J].Cancer Control,2015,22(4):489-497.
[6]Maltoni M,Caraceni A,Brunelli C,et al.Prognostic factors in advanced cancer patients:evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care[J].J Clin Oncol,2005,23(25):6240-6248.
[7]Berger AM,Yennu S,Million R.Update on interventions focused on symptom clusters:what has been tried and what have we learned?[J].Curr Opin Support Palliat Care,2013,7(1):60-66.
[8]吴晓丹,蒋超南,颜梅,等.食管癌根治术后化疗患者生活质量与症状困扰的相关性分析[J].中国实用护理杂志,2014,30(7):4-8.
[9]Maskell N.British Thoracic Society Pleural Disease Guidelines-2010 update[J].Thorax,2010,65(8):667-669.
[10]Debiasi EM,Pisani MA,Murphy TE,et al.Mortality among patients with pleural effusion undergoing thoracentesis[J].Eur Respir J,2015,46(2):495-502.
[11]Igor N,Suzana K,Miroslav S,et al.Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio help identify patients with lung cancer,but do not differentiate between lung cancer subtypes[J].Croat Med J,2016,57(3):287-292.
[12]Sanchez-Salcedo P,De-Torres JP,Martinez-Urbistondo D,et al.The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development[J].Lung Cancer,2016,97:28-34.
[13]Park DS,Dong K,Hwang KE,et al.Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions[J].Yonsei Med J,2013,54(2):396-402.
[14]Chen H,Hu N,Chang P,et al.Modified Glasgow Prognostic Score might be a prognostic factor for hepatocellular carcinoma:a meta-analysis[J].Panminerva Med,2016,59(4):302-307.
[15]宋旭敏,任青,程忠平.格拉斯哥预后评分预测肿瘤的临床价值[J].医学综述,2017,23(12):2354-2358.
[16]Young J,Badgery-Parker T,Dobbins T,et al.Comparison of ECOG/WHO performance status and ASA score as a measure of functional status[J].J Pain Symptom Manage,2015,49(2):258-264.
[17]于亚波,丛占杰.老年非小细胞肺癌ECOG评分、CYFRA21-1、NSE与外科手术预后关系[J].临床与实验病理学杂志,2017,33(7):806-809.
[18]Péus D,Newcomb N,Hofer S.Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation[J].BMC Med Inform Decis,2013,13(1):72-78.
[19]顾筱莉,成文武.晚期恶性肿瘤患者生存期影响因素的相关性分析[J].中国癌症杂志,2013,23(9):759-764.
[20]赵舞阳,王玉梅,崔檬,等.基于姑息预后指数(PPI)的晚期胃癌患者的生存分析[J].中国卫生统计,2017,34(6):900-903.
[21]Hui D,Kilgore K,Nguyen L,et al.The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer:a preliminary report[J].Oncologist,2011,16(11):1642-1648.
[22]Chuang RB,Hu WY,Chiu TY,et al.Prediction of survival in terminal cancer patients in Taiwan:constructing a Prognostic Scale[J].J Pain Symptom Manage,2004,28(2):115-122.
[23]Alzahrani AS,Elkashif AT,Mohammad AA,et al.Prediction of in-hospital mortality of patients with advanced cancer using the Chuang Prognostic Score[J].Am J Hosp Palliat Care,2013,30(7):707-711.
[24]Alsirafy SA,Zaki O,Sakr AY,et al.The use of the Chuang's Prognostic Scale to predict the survival of metastatic colorectal cancer patients receiving palliative systemic anticancer therapy[J].Indian J Palliat Care,2016,22(3):312-316.
[25]Pirovano M,Maltoni M,Nanni O,et al.A new Palliative Prognostic Score:a first step for the staging of terminally ill cancer patients[J].J Pain Symptom Manage,1999,17(4):231-239.
[26]Tassinari D,Montanari L,Maltoni M,et al.The Palliative Prognostic Score and survival in patients with advanced solid tumors receiving chemotherapy[J].Support Care Cancer,2008,16(4):359-370.
[27]Naylor C,Cerqueira L,Costa JV,et al.Survival of women with cancer in palliative care:use of the Palliative Prognostic Score in a population of Brazilian women[J].J Pain Symptom Manage,2010,39(1):69-75.
[28]Caraceni A,Nanni O,Maltoni M,et al.Impact of delirium on the short-term prognosis of advanced cancer patients.Italian multicenter study group on palliative care[J].Cancer,2000,89(5):1145-1149.
[29]Scarpi E,Maltoni M,Miceli R,et al.Survival prediction for terminally ill cancer patients:revision of the palliative prognostic score with incorporation of delirium[J].Oncologist,2011,16(12):1793-1799.
[30]顾君君,胡文琳,邱文娟,等.冠状动脉旁路移植术后患者谵妄持续时间及其对预后的影响[J].解放军护理杂志,2015,32(1):17-19.
[31]Morita T,Tsunoda J,Inoue S,et al.The Palliative Prognostic Index:a scoring system for survival prediction of terminally ill cancer patients[J].Support Care Cancer,1999,7(3):128-133.
[32]Anderson F,Downing GM,Hill J,et al.Palliative Performance Scale(PPS):a new tool[J].J Palliat Care,1996,12(1):5-11.
[33]曹文婷.TACE肝癌患者症状、症状群及生活质量的纵向研究[D].上海:第二军医大学,2012.
[34]Zhou LJ,Cui J,Lu J,et al.Prediction of survival time in advanced cancer:a prognostic scale for Chinese patients[J].J Pain Symptom Manage,2009,38(4):578-586.
[35]Huang Y,Xi Q,Xia S,et al.Development and validation of a Prognostic Scale for hospitalized patients with terminally ill cancer in China[J].Supportive Care in Cancer,2014,22(1):145-152.
[36]Bozcuk H,Koyuncu E,Yildiz M,et al.A simple and accurate prediction model to estimate the intra-hospital mortality risk of hospitalized cancer patients[J].Int J Clin Pract,2004,58(11):1014-1019.
[37]Gwilliam B,Keeley V,Todd C,et al.Development of Prognosis in Palliative Care Study(PiPS)predictor models to improve prognostication in advanced cancer:prospective cohort study[J].BMJ,2011,343:d4920:459-473.
[38]Lau F,Maida V,Downing M,et al.Use of the Palliative Performance Scale(PPS)for end-of-life prognostication in a palliative medicine consultation service[J].J Pain Symptom Manage,2009,37(6):965-972.
[39]Baba M,Maeda I,Morita T,et al.Survival prediction for advanced cancer patients in the real world:a comparison of the Palliative Prognostic Score,Delirium-Palliative Prognostic Score,Palliative Prognostic Index and modified Prognosis in Palliative Care Study predictor model[J].Eur J Cancer,2015,51(12):1618-1629.
[40]陆敏秋,褚彬,白砚霞,等.多发性骨髓瘤预后的影响因素研究[J].中国全科医学,2016,19(6):658-665.
[41]王粲霏,贾会英,吴珂,等.多学科协作模式在安宁疗护中的应用研究进展[J].中华护理杂志,2018,53(7):866-871.
[2]Kishi T,Matsuo Y,Ueki N,et al.Pretreatment Modified Glasgow Prognostic Score predicts clinical outcomes after stereotactic body radiation therapy for early-stage non-small cell lung cancer[J].Int J Radiat Oncol,2015,92(3):619-626.
[3]Hyman DM,Eaton AA,Gounder MM,et al.Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials[J].J Clin Oncol,2014,32(6):519-526.
[4]Jeba J,Cherian RM,Thangakunam B,et al.Prognostic factors of malignant pleural effusion among palliative care outpatients:a retrospective study[J].Indian J Palliat Care,2018,24(2):184-188.
[5]Hui D.Prognostication of survival in patients with advanced cancer:predicting the unpredictable[J].Cancer Control,2015,22(4):489-497.
[6]Maltoni M,Caraceni A,Brunelli C,et al.Prognostic factors in advanced cancer patients:evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care[J].J Clin Oncol,2005,23(25):6240-6248.
[7]Berger AM,Yennu S,Million R.Update on interventions focused on symptom clusters:what has been tried and what have we learned?[J].Curr Opin Support Palliat Care,2013,7(1):60-66.
[8]吴晓丹,蒋超南,颜梅,等.食管癌根治术后化疗患者生活质量与症状困扰的相关性分析[J].中国实用护理杂志,2014,30(7):4-8.
[9]Maskell N.British Thoracic Society Pleural Disease Guidelines-2010 update[J].Thorax,2010,65(8):667-669.
[10]Debiasi EM,Pisani MA,Murphy TE,et al.Mortality among patients with pleural effusion undergoing thoracentesis[J].Eur Respir J,2015,46(2):495-502.
[11]Igor N,Suzana K,Miroslav S,et al.Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio help identify patients with lung cancer,but do not differentiate between lung cancer subtypes[J].Croat Med J,2016,57(3):287-292.
[12]Sanchez-Salcedo P,De-Torres JP,Martinez-Urbistondo D,et al.The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development[J].Lung Cancer,2016,97:28-34.
[13]Park DS,Dong K,Hwang KE,et al.Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions[J].Yonsei Med J,2013,54(2):396-402.
[14]Chen H,Hu N,Chang P,et al.Modified Glasgow Prognostic Score might be a prognostic factor for hepatocellular carcinoma:a meta-analysis[J].Panminerva Med,2016,59(4):302-307.
[15]宋旭敏,任青,程忠平.格拉斯哥预后评分预测肿瘤的临床价值[J].医学综述,2017,23(12):2354-2358.
[16]Young J,Badgery-Parker T,Dobbins T,et al.Comparison of ECOG/WHO performance status and ASA score as a measure of functional status[J].J Pain Symptom Manage,2015,49(2):258-264.
[17]于亚波,丛占杰.老年非小细胞肺癌ECOG评分、CYFRA21-1、NSE与外科手术预后关系[J].临床与实验病理学杂志,2017,33(7):806-809.
[18]Péus D,Newcomb N,Hofer S.Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation[J].BMC Med Inform Decis,2013,13(1):72-78.
[19]顾筱莉,成文武.晚期恶性肿瘤患者生存期影响因素的相关性分析[J].中国癌症杂志,2013,23(9):759-764.
[20]赵舞阳,王玉梅,崔檬,等.基于姑息预后指数(PPI)的晚期胃癌患者的生存分析[J].中国卫生统计,2017,34(6):900-903.
[21]Hui D,Kilgore K,Nguyen L,et al.The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer:a preliminary report[J].Oncologist,2011,16(11):1642-1648.
[22]Chuang RB,Hu WY,Chiu TY,et al.Prediction of survival in terminal cancer patients in Taiwan:constructing a Prognostic Scale[J].J Pain Symptom Manage,2004,28(2):115-122.
[23]Alzahrani AS,Elkashif AT,Mohammad AA,et al.Prediction of in-hospital mortality of patients with advanced cancer using the Chuang Prognostic Score[J].Am J Hosp Palliat Care,2013,30(7):707-711.
[24]Alsirafy SA,Zaki O,Sakr AY,et al.The use of the Chuang's Prognostic Scale to predict the survival of metastatic colorectal cancer patients receiving palliative systemic anticancer therapy[J].Indian J Palliat Care,2016,22(3):312-316.
[25]Pirovano M,Maltoni M,Nanni O,et al.A new Palliative Prognostic Score:a first step for the staging of terminally ill cancer patients[J].J Pain Symptom Manage,1999,17(4):231-239.
[26]Tassinari D,Montanari L,Maltoni M,et al.The Palliative Prognostic Score and survival in patients with advanced solid tumors receiving chemotherapy[J].Support Care Cancer,2008,16(4):359-370.
[27]Naylor C,Cerqueira L,Costa JV,et al.Survival of women with cancer in palliative care:use of the Palliative Prognostic Score in a population of Brazilian women[J].J Pain Symptom Manage,2010,39(1):69-75.
[28]Caraceni A,Nanni O,Maltoni M,et al.Impact of delirium on the short-term prognosis of advanced cancer patients.Italian multicenter study group on palliative care[J].Cancer,2000,89(5):1145-1149.
[29]Scarpi E,Maltoni M,Miceli R,et al.Survival prediction for terminally ill cancer patients:revision of the palliative prognostic score with incorporation of delirium[J].Oncologist,2011,16(12):1793-1799.
[30]顾君君,胡文琳,邱文娟,等.冠状动脉旁路移植术后患者谵妄持续时间及其对预后的影响[J].解放军护理杂志,2015,32(1):17-19.
[31]Morita T,Tsunoda J,Inoue S,et al.The Palliative Prognostic Index:a scoring system for survival prediction of terminally ill cancer patients[J].Support Care Cancer,1999,7(3):128-133.
[32]Anderson F,Downing GM,Hill J,et al.Palliative Performance Scale(PPS):a new tool[J].J Palliat Care,1996,12(1):5-11.
[33]曹文婷.TACE肝癌患者症状、症状群及生活质量的纵向研究[D].上海:第二军医大学,2012.
[34]Zhou LJ,Cui J,Lu J,et al.Prediction of survival time in advanced cancer:a prognostic scale for Chinese patients[J].J Pain Symptom Manage,2009,38(4):578-586.
[35]Huang Y,Xi Q,Xia S,et al.Development and validation of a Prognostic Scale for hospitalized patients with terminally ill cancer in China[J].Supportive Care in Cancer,2014,22(1):145-152.
[36]Bozcuk H,Koyuncu E,Yildiz M,et al.A simple and accurate prediction model to estimate the intra-hospital mortality risk of hospitalized cancer patients[J].Int J Clin Pract,2004,58(11):1014-1019.
[37]Gwilliam B,Keeley V,Todd C,et al.Development of Prognosis in Palliative Care Study(PiPS)predictor models to improve prognostication in advanced cancer:prospective cohort study[J].BMJ,2011,343:d4920:459-473.
[38]Lau F,Maida V,Downing M,et al.Use of the Palliative Performance Scale(PPS)for end-of-life prognostication in a palliative medicine consultation service[J].J Pain Symptom Manage,2009,37(6):965-972.
[39]Baba M,Maeda I,Morita T,et al.Survival prediction for advanced cancer patients in the real world:a comparison of the Palliative Prognostic Score,Delirium-Palliative Prognostic Score,Palliative Prognostic Index and modified Prognosis in Palliative Care Study predictor model[J].Eur J Cancer,2015,51(12):1618-1629.
[40]陆敏秋,褚彬,白砚霞,等.多发性骨髓瘤预后的影响因素研究[J].中国全科医学,2016,19(6):658-665.
[41]王粲霏,贾会英,吴珂,等.多学科协作模式在安宁疗护中的应用研究进展[J].中华护理杂志,2018,53(7):866-871.